REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,159,482 | +45.1% | 344,328 | +27.1% | 0.01% | +50.0% |
| Q2 2023 | $2,866,154 | +244.3% | 270,903 | +220.2% | 0.01% | +200.0% |
| Q1 2023 | $832,494 | -33.1% | 84,603 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,244,510 | +13.0% | 84,603 | -6.8% | 0.00% | 0.0% |
| Q3 2022 | $1,101,000 | -7.8% | 90,803 | +6.4% | 0.00% | 0.0% |
| Q2 2022 | $1,194,000 | -26.0% | 85,323 | -24.7% | 0.00% | 0.0% |
| Q1 2022 | $1,614,000 | -17.1% | 113,294 | +22.7% | 0.00% | -25.0% |
| Q4 2021 | $1,947,000 | +282.5% | 92,324 | +375.9% | 0.00% | +300.0% |
| Q3 2021 | $509,000 | -15.9% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $605,000 | +1.7% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $595,000 | -10.7% | 19,400 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $666,000 | +11.6% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $597,000 | +862.9% | 19,400 | +870.0% | 0.00% | – |
| Q2 2020 | $62,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
| CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
| MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
| BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
| HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
| Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
| Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
| Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
| Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
| Artal Group S.A. | 700,000 | $6,888 | 0.41% |